Article may be outdated

This article is 9 days old. Some details may have changed since publication.

The Manila Times·4 min read·hard

Cytosurge’s CellEDIT Conquers "Impossible" Genome Engineering Challenges

Cytosurge’s CellEDIT Conquers "Impossible" Genome Engineering Challenges
AI Summary

Cytosurge AG and the Technical University of Denmark have published a study demonstrating the effectiveness of the CellEDIT platform in genome engineering. The research identifies dermokine as a key protein in skin cell adhesion, offering potential new treatments for chronic ulcers and skin cancer.

A new peer-reviewed study validates CellEDIT’s ability to overcome cell-editing barriers, uncovering dermokine’s pivotal role in wound healing and skin cancer biology.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
sciencehealthtechnology

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in